Detecting a psoriatic antigen analogous to infectious prion proteins

Cover Page

Cite item


Until now, psoriatic antigen as a specific antigen derived from some infectious agent potentially related to origin of psoriasis has not been identified, thereby strongly arguing against infectious theory of psoriasis. However, the lack of specific psoriasis-associated antigens may be theoretically accounted for by an idea that psoriatic antigen could be analogous to infectious prion proteins (PrPSc analogue). It might be identical to some epidermal protein in psoriasis-free subjects that might differ antigenically from related normal protein by resistance to digestive enzymes similarly to PrPSc. Since PrPSc cytopathogenic effect is associated with its location within cell structures of affected body tissue, by analogy with PrPSc we aimed at identifying a potential carrier of psoriatic antigen by examining peptic hydrolysates of psoriatic squamous elements. Psoriatic squamous elements and epidermal stratum corneum were collected from heel area of healthy subjects with a metal grater for further examination. Squamous elements were homogenized in isotonic saline followed by centrifugation to separate them from soluble components. Homogenates of squamous elements structures and their homogenate supernatants underwent peptic hydrolysis reaction. Antigens and their identity were analysed by Ouchterlony immunoprecipitation in agar with antiserum obtained after immunizing rabbits with homogenate of the psoriatic squamous element structures, before and after hydrolysis, using peptic hydrolysates of squamous element structures and relevant supernatants. It was found that two antigens were precipitated in peptic hydrolysates of homogenates of psoriatic squamous cell structures, underlying acidin-pepsin resistance of antigen carriers. However, compared to the remainder of antigens precipitated in examined substrates only one out of two antigens might be considered as a psoriatic antigen being some PrPSc analogue that was identical to one of supernatant antigens derived from epidermal stratum corneum homogenates collected from healthy subjects. Similar to PrPSc, it differed from antigenically related normal protein by acidin-pepsin resistance. Albeit confirming available reports revealing no psoriasis-associated pathogen-specific antigens, this, nonetheless, might not be sufficient for rejecting infectious theory of psoriasis, as psoriatic antigen exhibits some properties similar to those of PrPSc.

About the authors

B. F. Sinitsyn

S.I. Georgievsky Medical Academy, Crimean Federal V.I. Vernadsky University

Author for correspondence.

PhD (Medicine), Associate Professor, Associate Professor of the Department of Infectious Diseases,

295051, Simferopol, Lenin Boulevard, 5/7

Russian Federation


  1. Берзовски Дж.А., Берковер А.Дж. Взаимодействие антиген-антитело // Иммунология. Под ред. У. Пола; пер. с англ. Т.Н. Власик. М.: Мир, 1989. Т. 3. С. 5–88.
  2. Зуев В.А., Завалишин И.А., Ройхель В.М. Прионные болезни человека и животных. М.: Медицина, 1999. 192 с.
  3. Покровский В.И., Черкасский Б.Л. Специфика эпидемиологии инфекционных болезней. Руководство по эпидемиологии инфекционных болезней. Под ред. В.И. Покровского. М.: Медицина, 1993. Т. 1. С. 5–24.
  4. Синицын Б.Ф. Обнаружение аналога инфекционных прионных белков при псориазе в объяснении высокого риска фотоканцерогенеза при интенсивной инсоляции // Вестник физиотерапии и курортологии. 2017. Т. 23, № 3. С. 29–36.
  5. Тер-Аванесян М.Д. Феномен «прионизации» дрожжевых белков // Зуев В.А., Завалишин И.А., Ройхель В.М. Прионные болезни человека и животных. М.: Медицина, 1999. С. 161–170.
  6. Терлецкий О.В. Псориаз. Дифференциальная диагностика «псориазоподобных» редких дерматозов. Терапия. Медицинский атлас. СПб.: ДЕАН, 2007. 510 с.
  7. Altenburg A., Augustin M., Zouboulis C.C. [Side effects of biologic therapies in psoriasis]. Hautarzt, 2018, vol. 69, no. 4, рр. 290– 297. doi: 10.1007/s00105-018-4156-z. (In German).
  8. Ayala-Fontánez N., Soler D.C., McCormick T.S. Current knowledge on psoriasis and autoimmune diseases. Psoriasis (Auckl.), 2016, vol. 6, рр. 7–32. doi: 10.2147/PTT.S64950
  9. Ayroldi E., Bastianelli A., Cannarile L., Petrillo M.G., Delfino D.V., Fierabracci A. A pathogenetic approach to autoimmune skin disease therapy: psoriasis and biological drugs, unresolved issues, and future directions. Curr. Pharm. Des., 2011, vol. 17, no. 29, pp. 3176–3190.
  10. Batlle C., Iglesias V., Navarro S., Ventura S. Prion-like proteins and their computational identification in proteomes. Expert. Rev. Proteomics, 2017, vol. 14, no. 4, pp. 335–350. doi: 10.1080/14789450.2017.1304214
  11. Crow J.M. Psoriasis uncovered. Nature, 2012, vol. 492, no. 7429, pp. 50–51. doi: 10.1038/492S50a
  12. Juhlin L., Scheynius A., Klareskog L. Immunohistochemical reactivity of monoclonal antibodies generated after immunization of mice with cells from a psoriatic lesion. Acta Dermatovenerol., 1989, vol. 69, no. 2, pp. 93–100.
  13. Mälkonen T. Suomela S. What do we know about pathogenesis of psoriasis? Duodecim, 2011, vol. 127, no. 15, pp. 1579–1589.
  14. Mishra R.S., Basu S., Gu Y., Luo X., Zou W.Q., Mishra R., Li R., Chen S.G., Gambetti P., Fujioka H., Singh N. Proteaseresistant human prion protein and ferritin are cotransported across Caco-2 epithelial cells: implications for species barrier in prion uptake from the intestine. J. Neurosci., 2004, vol. 24, no. 50, pp. 11280–11290. doi: 10.1523/JNEUROSCI.2864-04.2004
  15. Shim S.Y., Karri S., Law S., Schatzl H.M., Gilch S. Prion infection impairs lysosomal degradation capacity by interfering with rab7 membrane attachment in neuronal cells. Sci Rep., 2016, vol. 6: 21658. doi: 10.1038/srep21658

Supplementary files

There are no supplementary files to display.

Copyright (c) 2019 Sinitsyn B.F.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 64788 от 02.02.2016.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies